Bank of America analysts say that they are bullish over the medtech industry as surgical procedure recoveries in recent months bode well for the field. In an analysis published yesterday, BofA said medtech management teams are likely remaining cautiously optimistic amid recovery efforts brough on by the impact of COVID-19, but they are growing in […]
Baxter’s dialysis filter wins De Novo nod
Baxter (NYSE:BAX) announced today that it received FDA De Novo classification for its Theranova novel dialysis membrane. Theranova is designed to deliver expanded hemodialysis (HDx) therapy, filtering a wider range of molecules from the blood than traditional hemodialysis (HD) filters, targeting certain molecules associated with inflammation and cardiovascular disease in patients with kidney failure, according to […]
The top 5 medtech CEO quotes about COVID-19
The latest earnings season not only provided insights from top medtech CEOs about how the COVID-19 pandemic is changing the industry, but also lessons learned going forward. Here are five top quotes about lessons learned. Next>> DeviceTalks editorial director Tom Salemi contributed to this report.
Baxter gains EUA for renal replacement tech for critically ill children
Baxter (NYSE:BAX) announced today that it received FDA emergency use authorization (EUA) for its HF20 Set and ST Set for continuous renal replacement therapy (CRRT). Under EUA, the HF20 Set can deliver CRRT to treat patients of low weight (8-20 kg) and low blood volume who can’t tolerate a larger extracorporeal circuit volume in an acute […]
DTW Podcast: 10 ways medtech is finding its footing amid COVID-19
When COVID-19 set upon the U.S. in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day. Over the past few weeks, medtech executives from several […]
MedTech 100 roundup: Industry hits another mid-pandemic high
Despite a minor regression week-over-week, the medtech industry’s stocks hit another milestone as the COVID-19 rebound remains in progress. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.01 points at the end of last week (July 31). Overall, medtech stocks saw a -0.3% increase from the […]
DTW: What in the world will Thrive Earlier Detection do with $257 million?
In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Dr. Isaac Kinde, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical […]
The top 5 MassDevice stories of the week — July 31, 2020
The past week has seen a slew of Q2 earnings reports from medical device companies — and the picture overall hasn’t been pretty amid the COVID-19 pandemic. Still, medtech CEOs during their earnings calls said they’re starting to see some signs of hospital procedures recovering a bit even as the southern U.S. deals with a […]
Baxter dips on missed Q2 projections
Baxter (NYSE:BAX) shares took a hit today on second-quarter financial results that came up short of the consensus forecast. The Deerfield, Ill.-based company posted profits of $247 million, or 48¢ per share, on sales of $2.7 billion for the three months ended June 30, 2020, for a 21.1% bottom-line slide) on a sales decline of -4.1%. […]
Baxter, Ayogo to provide digital health support for people with kidney failure
Baxter (NYSE:BAX) and Ayogo Health Inc. announced today that they are expanding their partnership to support people with kidney disease. The partnership between Deerfield, Ill.-based Baxter and Vancouver, B.C.-based Ayogo will combine the latter’s LifePlan behavior-based digital platform with Baxter’s renal care expertise to build mobile apps and digital solutions to support kidney failure patients, according […]
FDA clears new Baxter bone graft substitute
Baxter (NYSE:BAX) announced today that it received FDA clearance for its Altapore Shape bioactive bone graft for bone growth and fusion. Deerfield, Ill.-based Baxter’s Altapore Shape is its latest addition to its bone graft substitute product line, designed to enhance bone growth and aid in achieving fusion, leading to reduced pain and other improved clinical outcomes […]
- 1
- 2
- 3
- …
- 32
- Next Page »
